دورية أكاديمية
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile
العنوان: | Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile |
---|---|
المؤلفون: | Lorusso, DomenicaAff1, Aff2, Maltese, Giuseppa, Sabatucci, Ilaria, Cresta, Sara, Matteo, Cristina, Ceruti, Tommaso, D’Incalci, Maurizio, Zucchetti, Massimo, Raspagliesi, Francesco, Sonetto, Cristina, Sinno, Valentina, Ronzulli, Dominique, Giolitto, Serena, de Braud, FilippoAff3, Aff7 |
المصدر: | Targeted Oncology. 16(1):59-68 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 17762596 1776260X |
---|---|
DOI: | 10.1007/s11523-020-00780-4 |